Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J).

Shuji AsaiMochihito SuzukiRyota HaraYuji HiranoSatomi NagamineTetsuya KanekoTakahito SutoTadashi OkanoYutaka YoshiokaMakoto HiraoHiroki WakabayashiTakayoshi FujibayashiTatsuo WatanabeYuya TakakuboHajime IshikawaYoshihisa NasuToki TakemotoTakefumi KatoEiji TorikaiKensuke KoyamaHideki TakagiToshifumi FujiwaraYasumori SobueYoshifumi OhashiTsuyoshi NishiumeKenya TerabeMasayo KojimaToshihisa KojimaShiro Imagama

Published in: Modern rheumatology (2024)

Observations up to 6 months revealed that the effectiveness of MTX administered based on rheumatologist discretion in patients with LORA is comparable to that in patients with YORA in clinical settings.

Keyphrases

late onset
rheumatoid arthritis
early onset
randomized controlled trial
systematic review
disease activity
single cell
big data
machine learning
deep learning
interstitial lung disease
data analysis
clinical evaluation